Implementation of cerebral microdialysis at a community-based hospital: A 5-year retrospective analysis

BACKGROUND: Cerebral microdialysis (MD) provides valuable information about brain metabolism under normal and pathologic conditions. The CMA 600 microdialysis analyzer received US Food and Drug Administration (FDA) approval for clinical use in the United States in 2005. Since then, cerebral MD has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jeff W., Rogers, Shana L., Gombart, Zoe J., Adler, David E., Cecil, Sandy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385066/
https://www.ncbi.nlm.nih.gov/pubmed/22754722
http://dx.doi.org/10.4103/2152-7806.96868

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385066/
https://www.ncbi.nlm.nih.gov/pubmed/22754722
http://dx.doi.org/10.4103/2152-7806.96868

Ejemplares similares